The benefit of an injectable product is that it avoids the adherence issues related to taking a pill daily.
Articles on ARVs
Displaying all articles
When antiretroviral therapy is working effectively, HIV cannot be transmitted. This allows people with HIV to live fuller lives without the fear of infecting others.
Patients with low HIV viral loads are just as likely to harbour HIV variants with drug resistance mutations as those with high viral loads.
Cryptococcal ceningitis is one of the main causes of death of people with HIV. The tests and medicines to diagnose and treat it exist but remain inaccessible to most. A global strategy is needed.
Very little is known about the relationship between COVID-19 and HIV and TB. What is known is that people’s lungs are affected by all three.
Providing antiretroviral therapy without incorporating quality diets may not help to reduce illness and death related to HIV.
Communities continue to be vital in efforts to bring the pandemic under control. They are the custodians of rich knowledge that creates the context in which HIV transmission occurs.
The study confirms that dolutegravir is an effective and well-tolerated ARV.
The government needs to revise national guidelines to better target PrEP at those that would most benefit from it.
Until then we need to get effective, accessible treatment for all who need it, while deploying the many prevention tools at our disposal.
HIV negative children born to women with HIV have a greater risk of dying before their first birthday.
Doctors in South Africa performed a liver transplant from an HIV-positive donor to a HIV-negative recipient. Major ethical questions came into play.
Stigma stops people from getting tested for HIV, and staying on their treatment. Unless it’s addressed, the AIDS epidemic will persist.
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
Current epidemiological and financial trends suggest there’s a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.
Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.
Top contributors
-
Communications Officer for the Sub-Saharan African Network for TB/HIV Research Excellence
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Head of Transplants at Donald Gordon Medical Centre, University of the Witwatersrand
-
Honorary Prof. of Clinical Pharmacology,, University of Cape Town
-
Senior lecturer in Paediatrics and Child Health, Stellenbosch University
-
Bioethicist and Health Communication Specialist, University of the Witwatersrand
-
Assistant Professor, Harvard University
-
Research Director at Donald Gordon Medical Centre, University of the Witwatersrand
-
Associate Professor and Director of the Centre for Infectious Diseases Epidemiology and Research, University of Cape Town
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Researcher, University of the Witwatersrand
-
Principal Investigator and Research Associate at Botswana Harvard AIDS Institute Partnership, Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Public Health Medicine Specialist, University of the Witwatersrand